Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer
- 21 September 2014
- journal article
- Published by Elsevier BV in Clinical Genitourinary Cancer
- Vol. 13 (2), 130-136
- https://doi.org/10.1016/j.clgc.2014.08.014
Abstract
No abstract availableKeywords
Funding Information
- NIH (K12 2K12CA001727-16A1)
- Tower Foundation
This publication has 21 references indexed in Scilit:
- Cadherins and Epithelial-to-Mesenchymal TransitionPublished by Elsevier BV ,2013
- Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen ReceptorPLOS ONE, 2012
- The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and β-catenin, in prostate cancerUrologic Oncology, 2010
- Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate CancerScience Translational Medicine, 2010
- Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerJournal of Oncology, 2009
- The basics of epithelial-mesenchymal transitionJCI Insight, 2009
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2008
- Circulating Tumor Cells in Peripheral Blood Samples From Patients With Increased Serum Prostate Specific Antigen: Initial Results in Early Prostate CancerJournal of Urology, 2008
- A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate CancerClinical Cancer Research, 2007
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999